AzTrials
AzTrials

Primary DysmenorrheaNCT06990815

Immediate Effects of Kinesio Taping in Primary Dysmenorrhea

A study testing Kinesio Taping in people with Primary Dysmenorrhea, run by Okan University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary dysmenorrhea is characterized by recurrent, cramping lower abdominal pain during menstruation and affects approximately 50% to 90% of women. The etiology of primary dysmenorrhea involves the increased release of prostaglandins and other inflammatory mediators, which cause uterine contractions and reduced blood… Read more about this study

Who is it for?
Ages 18 to 24 years, women only
Conditions the study is for
Primary Dysmenorrhea
What is being tested?
Kinesio Taping
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteTurkey (Türkiye)
Study dates
19 Aug 2023to 23 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being a nulliparous woman aged between 18 and 24 years
  • Having a diagnosis of primary dysmenorrhea confirmed by a physician,
  • Being literate
  • Cooperating in completing the assessment scales
  • Scoring one or above on the Weissman Scale
  • Agreeing to participate in the study
  • Having regular menstruation in the last 6 months
  • Being willing and voluntary to participate in the research.

Who cannot join

  • Having a diagnosis of secondary dysmenorrhea
  • Using contraceptive pills
  • Having a history of childbirth or pregnancy
  • Having irregular menstrual cycles (menstrual cycle length less than 21 days or longer than 35 days)
  • Having any pelvic pathology or history of pelvic surgery
  • Having gastrointestinal, urogynecological, autoimmune, psychiatric, neurological diseases, or other chronic pain syndromes.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Okan University

    Istanbul, 34010

Other trials in Turkey (Türkiye)

About this study

Official title: The Immediate Effect of Kinesio Taping on Pain, Menstrual Symptoms, Fear of Movement, and Sleep Quality in Primary Dysmenorrhea: A Randomized Sham-Controlled Trial

Primary dysmenorrhea is characterized by recurrent, cramping lower abdominal pain during menstruation and affects approximately 50% to 90% of women. The etiology of primary dysmenorrhea involves the increased release of prostaglandins and other inflammatory mediators, which cause uterine contractions and reduced blood flow. In addition to pharmacological approaches, non-pharmacological methods also play an important role in the treatment of dysmenorrhea.

Kinesio taping helps relieve pain by reducing pressure on the muscle and supports treatment through various application techniques. It improves local circulation, reduces muscle tension, and alleviates symptoms of primary dysmenorrhea.

Read more

The aim of this study is to investigate the effects of kinesio taping on pain, menstrual symptoms, fear of movement, and sleep quality in women with primary dysmenorrhea, and to compare the outcomes with those of a sham taping group.

The hypothesis is that kinesio taping will be more effective than sham taping in improving these parameters in women with primary dysmenorrhea.

Being tested
Kinesio Taping, Sham
Keywords
Kinesio Taping, Pain, Menstrual Symptoms, Fear of Movement, Sleep Quality
Medical subject headings
Pain, Kinesiophobia, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kinesio TapingOther

    In the application over the sacrum, one I-strip of kinesio tape will be applied with 25% tension using the fascia correction technique, which requires oscillatory movements between the tape and the skin.

    In the application over the suprapubic region, two I-strips will be applied with 25% tension, also using the fascia correction technique, involving oscillations between the tape and the skin.

  • ShamOther

    In the application over the sacrum, one I-strip will be applied without tension.

    In the application over the suprapubic region, two I-strips will be placed without tension.

Study groups in NCT06990815
Study groupRoleWhat they receive
Kinesio Taping GroupExperimentalNot described
Receives: Other: Kinesio Taping
Sham Control GroupSham comparatorNot described
Receives: Other: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale

    Pain will be assessed using the Visual Analog Scale. On the Visual Analog Scale, a score of '0' indicates no pain, while '10' represents the most unbearable pain on a 10 cm horizontal line. It is a simple, practical, valid, reliable, and reproducible measurement tool.

    Measured: 2 weeks

  2. Menstrual Symptom Questionnaire

    The Menstrual Symptom Questionnaire (MSQ) was originally developed by Chesney and Tasto in 1975 to evaluate menstrual pain and related symptoms. Participants rate the severity of symptoms they experience during menstruation on a scale from 1 (never) to 5 (always).

    In this scale:

    Items 1-13 assess negative effects, Items 14-19 assess menstrual pain symptoms, and Items 20-22 assess coping methods. As the average score of each subscale increases, it indicates a higher severity of menstrual symptoms related to that subscale.

    Measured: 2 weeks

  3. Menstrual Attitude and Behavior Scale

    The Menstrual Attitude and Behavior Scale will be used to assess individuals' attitudes and behaviors during the menstrual period. This scale, also known as the Menstrual Attitude Questionnaire, consists of 33 items divided into five subscales:

    Menstruation as a debilitating event - 12 items Menstruation as a bothersome event - 6 items Menstruation as a natural event - 5 items Anticipation of the onset of menstruation - 5 items Denial of menstrual effects - 7 items Each subscale provides insight into specific attitudes and perceptions related to menstruation.

    Measured: 2 weeks

  4. Tampa Scale of Kinesiophobia

    Fear of movement will be assessed using the Tampa Scale of Kinesiophobia. The scale uses a 4-point Likert-type scoring system, and the total score ranges from 17 to 68.

    Higher scores indicate a greater fear of movement.

    Measured: 2 weeks

  5. Richard Campbell Sleep Questionnaire

    The Richard Campbell Sleep Questionnaire was developed by Richards in 1987 to assess sleep depth, time taken to fall asleep, number of awakenings, duration of wakefulness after sleep onset, sleep quality, and environmental noise level.

    It consists of 6 items, each evaluated using a visual analog scale ranging from 0 to 100. A score between 0-25 indicates very poor sleep, while a score between 76-100 reflects very good sleep. The total score is calculated based on 5 items; the 6th item, which evaluates environmental noise level, is excluded from the total score. Higher total scores indicate better sleep quality.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2025
  2. Study start19 Aug 2023
  3. Primary completion15 Dec 2023
  4. Study completion23 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06990815
Sponsor's protocol ID
12.4.2023/6
Status last verified
Apr 2026
First submitted
17 May 2025
Last updated
17 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Kinesio Taping in people with Primary Dysmenorrhea, run by Okan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (time frame: 2 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in